In recent years right ventricular septal pacing (RVSP) has been performed instead of right ventricular apical pacing (RVAP) because of the detrimental effects on the ventricular function associated with the latter type of pacing. However, little information has been available on the comparison of the cardiac function between RVAP and RVSP in individual patients. Therefore, we compared the changes in the cardiac index (CI) between RVAP and RVSP (right ventricular outflow tract or mid-ventricular tract) in each patient in whom a permanent pacemaker was implanted. We measured both the QRS duration and acute phase of the cardiac function by means of a Swan-Ganz catheter and compared the results between RVAP and RVSP. RVSP was associated with a shorter QRS duration (139:5 AE 4:6 vs. 180:6 AE 4:6 msec, p < 0:0001) in comparison to RVAP. Although there was no significant difference in the CI between the 2 pacing positions (2:71 AE 0:12 vs. 2:74 AE 0:13 L/min/m 2 , p ¼ 0:6969), the CI among the patients with complete atrioventricular block (cAVB) had a strong tendency of being better with RVSP patients (2:65 AE 0:19 vs. 2:84 AE 0:19 L/min/m 2 , p ¼ 0:1444). It is suggested that the beneficial effect of RVSP differs according to the causal disorder for pacemaker implantation. (J Arrhythmia 2009; 25: 70-76) 
Introduction
The implantation of permanent pacemakers has become an established technique for treating bradyarrhythmias such as sick sinus syndrome (SSS) or atrioventricular block (AVB) over the last several decades. With this technique, right ventricular apical pacing (RVAP) is a common methodology to preserve a desirable heart rate. However, several studies have shown that RVAP may bring about an inappropriate ventricular function during long term observation. [1] [2] [3] [4] [5] To avoid this disadvantage of RVAP, right ventricular septal pacing (RVSP) has been highlighted as a new ventricular pacing method. [6] [7] [8] Most investigations have targeted the comparison of the cardiac function between the patient groups with RVAP and RVSP. However, there is little information on the difference in the cardiac function between the two pacing sites in the same individuals. 9, 10) To elucidate this difference, we compared the change in the cardiac index (CI) between RVAP and RVSP immediately before the permanent pacemaker implantation procedure in the patients with bradyarrhythmias. Here RVSP means pacing in the outflow tract (RVOT) or mid-ventricular tract of the right ventricular septal aspect (RVMS).
Patients and Methods
Patient recruitment began August 9, 2007, and ended June 22, 2008, and 21 patients were enrolled. Patient characteristics are shown in Table 1 . In each patient, a pacing lead was initially positioned in the right atrial appendage. The ventricular lead was initially positioned in the RVA, and later moved to the RVOT or RVMS. Each ventricular lead site placement was determined by means of the 12-lead Figure 1 Typical electrocardiographic appearance at each pacing site surface electrocardiogram (ECG) (Figure 1) , and fluoroscopic radiographs ( Figure 2 ). The order of ventricular pacing lead positioning was switched randomly case by case. In both positions, DDD pacing was utilized except in the case of atrial fibrillation (AF). Though the pacing rate and AV delay differed among patients according to the P rate and PQ duration, the same pacing rate and AV delay were seen in each patient. The paced QRS duration was obtained from the ECG, especially in lead II. After pacing for five minutes, the CI was measured five times by means of a thermodilution method with a Swan-Ganz catheter ( Table 2) , and the average of three CIs, excluding the upper and lower CI, was calculated. Finally, all patients received an implantation of a permanent pacemaker with a ventricular pacing site in the RVOT or RVMS. All statistics were calculated by means of a paired t-test. This study was approved by all patients who participated in the study, and informed consent was obtained from all patients.
Results
Twenty-one patients were included in the analysis ( Table 1) . Each hemodynamic parameter exhibited no significant difference between the pacing positions ( Table 3) . RVSP was associated with a significantly shorter QRS duration in comparison with RVAP (139:5 AE 4:6 vs. 180:6 AE 4:6 msec, p < 0:0001) (Figure 3 ). There was no significant difference in the CI between RVAP and RVSP (2:71 AE 0:12 vs. SSS (n ¼ 7) and advanced AVB (aAVB) patient groups (n ¼ 6) showed no significant difference ( Figure 4) . When the patients were divided into groups according to degree of reduction in the QRS duration of more than 37 msec or less than 36 msec with the RVSP, the former patient group showed a tendency toward having a higher CI during RVSP than RVAP (2:97 AE 0:19 vs. 2:85 AE 0:20 L/min/m 2 , p ¼ 0:2213) whereas the latter exhibited no change or had rather a lower CI during RVSP (2:49 AE 0:14 vs. 2:56 AE 0:13 L/min/m 2 , p ¼ 0:4088) ( Figure 5 ). When the patients were divided into groups 173.1 ± 6.6
124.6 ± 6.5
Figure 6 QRS duration during RVSP

Discussion
The main finding in this study was that there was no significant difference in the CI of the acute phase between the RVSP and RVAP in any of the patients; however, the RVSP was associated with a significantly shorter QRS duration than the RVAP. This result suggested that the RVSP provided only a small advantage for the cardiac function in the patient group with a relatively normal left ventricular function. However, it was postulated that the advantage of the RVSP could have been overt when the background disorder of the patients was limited to cAVB. An additional finding was that the degree of the reduction in the QRS was deeply related to the improvement in the cardiac function during the RVSP pacing although the difference in the CI was not statistically significant. As it is possible to observe the diminishment in the QRS duration with RVSP during the pacemaker implantation procedure, it can be a desirable parameter for predicting the effect of the RVSP. Though there must be many other factors associated with the improvement in the cardiac function depending on the ventricular pacing site, one factor associated with RVSP providing a better CI than RVAP is considered to be the improvement in the dyssynchrony of the left ventricular wall motion. Further study is needed to adequately stratify the patients in order to utilize the beneficial effects of RVSP.
Conclusions
In this acute phase study, it was suggested that the tendency of the beneficial effects of RVSP is based on the existence of atrioventricular conduction disorder and the degree of reduction in the QRS duration. Further investigation and a long term observation will be needed to judge the beneficial effects of RVSP in comparison to RVAP.
